Skip to main content
Drug bottle and Pill

Compare Tasmar vs. Sinemet

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tolcapone (Tasmar) and carbidopa/levodopa (Sinemet) are both medications used to treat Parkinson's disease (PD). They help manage symptoms like shakiness and slow movement. However, they belong to different medication classes. Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor, while carbidopa/levodopa is a combination of a dopa decarboxylase inhibitor and dopamine replacement. Carbidopa/levodopa is a first-choice treatment, while tolcapone is only used as an add-on treatment with carbidopa/levodopa when the latter isn't enough to control PD symptoms. Tolcapone is taken three times a day, while carbidopa/levodopa comes in various forms and is taken multiple times a day depending on the form. Tolcapone can cause serious liver damage, so regular liver monitoring is needed. Carbidopa/levodopa can cause dark-colored urine and saliva and may make you very sleepy. Both medications can cause hallucinations and changes in behavior. Both medications are available as a lower-cost generic.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.